Kathryn Victoria Papp, M.S. - Publications

Affiliations: 
University of Connecticut, Storrs, CT, United States 
Area:
Clinical Neuropsychology & Neurorehabilitation

101 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Klinger HM, Healy BC, Hanseeuw BJ, Jones RN, Boyle R, Townsend DL, Properzi MJ, Coughlan GT, Seto M, Birkenbihl C, Farrell ME, Papp KV, Chhatwal JP, Yang HS, Schultz AP, et al. Latent change-on-change between amyloid accumulation and cognitive decline. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 39470175 DOI: 10.1002/alz.14326  0.389
2024 Boyle R, Townsend DL, Klinger HM, Scanlon CE, Yuan Z, Coughlan GT, Seto M, Shirzadi Z, Yau WW, Jutten RJ, Schneider C, Farrell ME, Hanseeuw BJ, Mormino EC, Yang HS, ... Papp KV, et al. Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegeneration. Alzheimer's Research & Therapy. 16: 148. PMID 38961512 DOI: 10.1186/s13195-024-01510-y  0.706
2024 Dubbelman MA, Diez I, Gonzalez C, Amariglio RE, Becker JA, Chhatwal JP, Gatchel JR, Johnson KA, Locascio JJ, Udeogu OJ, Wang S, Papp KV, Properzi MJ, Rentz DM, Schultz AP, et al. Amyloid and tau burden relate to longitudinal changes in the performance of complex everyday activities among cognitively unimpaired older adults: results from the performance-based Harvard Automated Phone Task. Frontiers in Aging Neuroscience. 16: 1420290. PMID 38934017 DOI: 10.3389/fnagi.2024.1420290  0.415
2024 Seto M, Hohman TJ, Mormino EC, Papp KV, Amariglio RE, Rentz DM, Johnson KA, Schultz AP, Sperling RA, Buckley RF, Yang HS. Parental History of Memory Impairment and β-Amyloid in Cognitively Unimpaired Older Adults. Jama Neurology. PMID 38884955 DOI: 10.1001/jamaneurol.2024.1763  0.402
2024 Pahl J, Prokopiou PC, Bueichekú E, Schultz AP, Papp KV, Farrell ME, Rentz DM, Sperling RA, Johnson KA, Jacobs HIL. Locus coeruleus integrity and left frontoparietal connectivity provide resilience against attentional decline in preclinical alzheimer's disease. Alzheimer's Research & Therapy. 16: 119. PMID 38822365 DOI: 10.1186/s13195-024-01485-w  0.684
2024 Schneider C, Prokopiou PC, Papp KV, Engels-Domínguez N, Hsieh S, Juneau TA, Schultz AP, Rentz DM, Sperling RA, Johnson KA, Jacobs HIL. Atrophy links lower novelty-related locus coeruleus connectivity to cognitive decline in preclinical AD. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38676563 DOI: 10.1002/alz.13839  0.673
2024 Bueichekú E, Diez I, Kim CM, Becker JA, Koops EA, Kwong K, Papp KV, Salat DH, Bennett DA, Rentz DM, Sperling RA, Johnson KA, Sepulcre J, Jacobs HIL. Spatiotemporal patterns of locus coeruleus integrity predict cortical tau and cognition. Nature Aging. PMID 38664576 DOI: 10.1038/s43587-024-00626-y  0.667
2024 Shirzadi Z, Boyle R, Yau WW, Coughlan G, Fu JF, Properzi MJ, Buckley RF, Yang HS, Scanlon CE, Hsieh S, Amariglio RE, Papp K, Rentz D, Price JC, Johnson KA, et al. Vascular contributions to cognitive decline: Beyond amyloid and tau in the Harvard aging brain study. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X241237624. PMID 38452039 DOI: 10.1177/0271678X241237624  0.392
2024 Burling JE, Katz Z, Yuan Z, Munro C, Mimmack K, Ma G, Hanseeuw BJ, Papp KV, Amariglio RE, Vannini P, Rentz DM, Quiroz YT, Johnson KA, Sperling RA, Blacker D, et al. Study Partner Report of Apathy in Older Adults is Associated with AD Biomarkers: Findings from the Harvard Aging Brain Study. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 38443298 DOI: 10.1016/j.jagp.2024.01.020  0.317
2023 Papp KV, Jutten RJ, Soberanes D, Weizenbaum E, Hsieh S, Molinare C, Buckley R, Betensky RA, Marshall GA, Johnson KA, Rentz DM, Sperling R, Amariglio RE. Early detection of amyloid-related changes in memory among cognitively unimpaired older adults with daily digital testing. Annals of Neurology. PMID 37991080 DOI: 10.1002/ana.26833  0.439
2023 Jutten RJ, Amariglio RE, Maruff P, Properzi MJ, Rentz DM, Johnson KA, Sperling RA, Papp KV. Increased intraindividual variability in reaction time performance is associated with emerging cognitive decline in cognitively unimpaired adults. Neuropsychology. PMID 37971861 DOI: 10.1037/neu0000928  0.358
2023 Hanseeuw BJ, Jacobs HI, Schultz AP, Buckley RF, Farrell ME, Guehl NJ, Becker JA, Properzi M, Sanchez JS, Quiroz YT, Vannini P, Sepulcre J, Yang HS, Chhatwal JP, Gatchel J, ... ... Papp K, et al. Association of pathological and volumetric biomarker changes with cognitive decline in clinically normal adults: Harvard Aging Brain Study. Neurology. PMID 37968130 DOI: 10.1212/WNL.0000000000207962  0.733
2023 Gagliardi G, Rodriguez-Vieitez E, Montal V, Sepulcre J, Diez I, Lois C, Hanseeuw B, Schultz AP, Properzi MJ, Papp KV, Marshall GA, Fortea J, Johnson KA, Sperling RA, Vannini P. Cortical microstructural changes predict tau accumulation and episodic memory decline in older adults harboring amyloid. Communications Medicine. 3: 106. PMID 37528163 DOI: 10.1038/s43856-023-00324-7  0.408
2023 Prokopiou PC, Engels-Domínguez N, Schultz AP, Sepulcre J, Koops EA, Papp KV, Marshall GA, Normandin MD, El Fakhri G, Rentz D, Sperling RA, Johnson KA, Jacobs HIL. Association of Novelty-Related Locus Coeruleus Function With Entorhinal Tau Deposition and Memory Decline in Preclinical Alzheimer Disease. Neurology. PMID 37491329 DOI: 10.1212/WNL.0000000000207646  0.651
2023 Reynolds G, Buckley R, Papp K, Schultz SA, Rentz D, Sperling R, Amariglio R. Relation of modifiable lifestyle and mood factors to cognitive concerns among participants and their study partners in the A4 screen data. Alzheimer's & Dementia (Amsterdam, Netherlands). 15: e12435. PMID 37304049 DOI: 10.1002/dad2.12435  0.426
2023 Gonzalez C, Mimmack KJ, Amariglio RE, Becker JA, Chhatwal JP, Fitzpatrick CD, Gatchel JR, Johnson KA, Katz ZS, Kuppe MK, Locascio JJ, Udeogu OJ, Papp KV, Premnath P, Properzi MJ, et al. Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings. Journal of Alzheimer's Disease : Jad. PMID 37212093 DOI: 10.3233/JAD-220885  0.461
2023 Young CB, Mormino EC, Poston KL, Johnson KA, Rentz DM, Sperling RA, Papp KV. Computerized cognitive practice effects in relation to amyloid and tau in preclinical Alzheimer's disease: Results from a multi-site cohort. Alzheimer's & Dementia (Amsterdam, Netherlands). 15: e12414. PMID 36950699 DOI: 10.1002/dad2.12414  0.445
2022 Öhman F, Berron D, Papp KV, Kern S, Skoog J, Hadarsson Bodin T, Zettergren A, Skoog I, Schöll M. Unsupervised mobile app-based cognitive testing in a population-based study of older adults born 1944. Frontiers in Digital Health. 4: 933265. PMID 36426215 DOI: 10.3389/fdgth.2022.933265  0.337
2022 Fristed E, Skirrow C, Meszaros M, Lenain R, Meepegama U, Papp KV, Ropacki M, Weston J. Leveraging speech and artificial intelligence to screen for early Alzheimer's disease and amyloid beta positivity. Brain Communications. 4: fcac231. PMID 36381988 DOI: 10.1093/braincomms/fcac231  0.464
2022 Skirrow C, Meszaros M, Meepegama U, Lenain R, Papp KV, Weston J, Fristed E. Validation of a Remote and Fully Automated Story Recall Task to Assess for Early Cognitive Impairment in Older Adults: Longitudinal Case-Control Observational Study. Jmir Aging. 5: e37090. PMID 36178715 DOI: 10.2196/37090  0.422
2022 Jutten RJ, Papp KV, Hendrix S, Ellison N, Langbaum JB, Donohue MC, Hassenstab J, Maruff P, Rentz DM, Harrison J, Cummings J, Scheltens P, Sikkes SAM. Why a clinical trial is as good as its outcome measure: A framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36086926 DOI: 10.1002/alz.12773  0.365
2022 Hampton OL, Mukherjee S, Properzi MJ, Schultz AP, Crane PK, Gibbons LE, Hohman TJ, Maruff P, Lim YY, Amariglio RE, Papp KV, Johnson KA, Rentz DM, Sperling RA, Buckley RF. Harmonizing the preclinical Alzheimer cognitive composite for multicohort studies. Neuropsychology. PMID 35862098 DOI: 10.1037/neu0000833  0.391
2022 Farrell ME, Papp KV, Buckley RF, Jacobs HIL, Schultz AP, Properzi MJ, Vannini P, Hanseeuw BJ, Rentz DM, Johnson KA, Sperling RA. Association of Emerging β-Amyloid and Tau Pathology With Early Cognitive Changes in Clinically Normal Older Adults. Neurology. PMID 35338074 DOI: 10.1212/WNL.0000000000200137  0.708
2022 Prokopiou PC, Engels-Domínguez N, Papp KV, Scott MR, Schultz AP, Schneider C, Farrell ME, Buckley RF, Quiroz YT, El Fakhri G, Rentz DM, Sperling RA, Johnson KA, Jacobs HIL. Lower novelty-related locus coeruleus function is associated with Aβ-related cognitive decline in clinically healthy individuals. Nature Communications. 13: 1571. PMID 35322012 DOI: 10.1038/s41467-022-28986-2  0.701
2022 Jutten RJ, Rentz DM, Fu JF, Mayblyum DV, Amariglio RE, Buckley RF, Properzi MJ, Maruff P, Stark CE, Yassa MA, Johnson KA, Sperling RA, Papp KV. Monthly At-Home Computerized Cognitive Testing to Detect Diminished Practice Effects in Preclinical Alzheimer's Disease. Frontiers in Aging Neuroscience. 13: 800126. PMID 35095476 DOI: 10.3389/fnagi.2021.800126  0.397
2021 Grober E, Papp KV, Rentz DM, Sperling RA, Johnson KA, Amariglio RE, Schultz A, Lipton RB, Ezzati A. Neuroimaging correlates of Stages of Objective Memory Impairment (SOMI) system. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12224. PMID 35005192 DOI: 10.1002/dad2.12224  0.357
2021 Papp KV, Samaroo A, Chou HC, Buckley R, Schneider OR, Hsieh S, Soberanes D, Quiroz Y, Properzi M, Schultz A, García-Magariño I, Marshall GA, Burke JG, Kumar R, Snyder N, et al. Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12243. PMID 34621977 DOI: 10.1002/dad2.12243  0.481
2021 Rodriguez-Vieitez E, Montal V, Sepulcre J, Lois C, Hanseeuw B, Vilaplana E, Schultz AP, Properzi MJ, Scott MR, Amariglio R, Papp KV, Marshall GA, Fortea J, Johnson KA, Sperling RA, et al. Association of cortical microstructure with amyloid-β and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults. Molecular Psychiatry. PMID 34588623 DOI: 10.1038/s41380-021-01290-z  0.515
2021 Jacobs HIL, Becker JA, Kwong K, Engels-Domínguez N, Prokopiou PC, Papp KV, Properzi M, Hampton OL, d'Oleire Uquillas F, Sanchez JS, Rentz DM, El Fakhri G, Normandin MD, Price JC, Bennett DA, et al. In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer's disease pathology and cognitive decline. Science Translational Medicine. 13: eabj2511. PMID 34550726 DOI: 10.1126/scitranslmed.abj2511  0.68
2021 Öhman F, Hassenstab J, Berron D, Schöll M, Papp KV. Current advances in digital cognitive assessment for preclinical Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12217. PMID 34295959 DOI: 10.1002/dad2.12217  0.408
2021 Mayblyum DV, Becker JA, Jacobs HIL, Buckley RF, Schultz AP, Sepulcre J, Sanchez JS, Rubinstein ZB, Katz SR, Moody KA, Vannini P, Papp KV, Rentz DM, Price JC, Sperling RA, et al. Comparing PET and MRI Biomarkers Predicting Cognitive Decline in Preclinical Alzheimer Disease. Neurology. PMID 33952655 DOI: 10.1212/WNL.0000000000012108  0.656
2021 Rentz DM, Papp KV, Mayblyum DV, Sanchez JS, Klein H, Souillard-Mandar W, Sperling RA, Johnson KA. Association of Digital Clock Drawing with PET Amyloid and Tau Pathology in Normal Older Adults. Neurology. PMID 33589537 DOI: 10.1212/WNL.0000000000011697  0.368
2021 Papp KV, Rentz DM, Maruff P, Sun CK, Raman R, Donohue MC, Schembri A, Stark C, Yassa MA, Wessels AM, Yaari R, Holdridge KC, Aisen PS, Sperling RA. The Computerized Cognitive Composite (C3) in an Alzheimer's Disease Secondary Prevention Trial. The Journal of Prevention of Alzheimer's Disease. 8: 59-67. PMID 33336226 DOI: 10.14283/jpad.2020.38  0.458
2020 Rentz DM, Papp KV. Commentary on Composite cognitive and functional measures for early stage Alzheimer's disease trials. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12012. PMID 33521233 DOI: 10.1002/dad2.12012  0.397
2020 Samaroo A, Amariglio RE, Burnham S, Sparks P, Properzi M, Schultz AP, Buckley R, Johnson KA, Sperling RA, Rentz DM, Papp KV. Diminished Learning Over Repeated Exposures (LORE) in preclinical Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12132. PMID 33426266 DOI: 10.1002/dad2.12132  0.394
2020 Farrell ME, Jiang S, Schultz AP, Properzi MJ, Price JC, Becker JA, Jacobs HIL, Hanseeuw BJ, Rentz DM, Villemagne VL, Papp KV, Mormino EC, Betensky RA, Johnson KA, Sperling RA, et al. Defining the lowest threshold for amyloid-PET to predict future cognitive decline and amyloid accumulation. Neurology. PMID 33199430 DOI: 10.1212/WNL.0000000000011214  0.667
2020 Dubbelman MA, Jutten RJ, Tomaszewski Farias SE, Amariglio RE, Buckley RF, Visser PJ, Rentz DM, Johnson KA, Properzi MJ, Schultz A, Donovan N, Gatchell JR, Teunissen CE, Van Berckel BNM, Van der Flier WM, ... ... Papp KV, et al. Decline in cognitively complex everyday activities accelerates along the Alzheimer's disease continuum. Alzheimer's Research & Therapy. 12: 138. PMID 33121534 DOI: 10.1186/s13195-020-00706-2  0.447
2020 Jutten RJ, Sikkes SAM, Amariglio RE, Buckley RF, Properzi MJ, Marshall GA, Rentz DM, Johnson KA, Teunissen CE, Van Berckel BNM, Van der Flier WM, Scheltens P, Sperling RA, Papp KV, et al. Identifying Sensitive Measures of Cognitive Decline at Different Clinical Stages of Alzheimer's Disease. Journal of the International Neuropsychological Society : Jins. 1-13. PMID 33046162 DOI: 10.1017/S1355617720000934  0.481
2020 Rabin JS, Neal TE, Nierle HE, Sikkes SAM, Buckley RF, Amariglio RE, Papp KV, Rentz DM, Schultz AP, Johnson KA, Sperling RA, Hedden T. Multiple markers contribute to risk of progression from normal to mild cognitive impairment. Neuroimage. Clinical. 28: 102400. PMID 32919366 DOI: 10.1016/J.Nicl.2020.102400  0.483
2020 Vila-Castelar C, Muñoz N, Papp KV, Amariglio RE, Baena A, Guzmán-Vélez E, Bocanegra Y, Sanchez JS, Reiman EM, Johnson KA, Sperling RA, Lopera F, Rentz DM, Quiroz YT. The Latin American Spanish version of the Face-Name Associative Memory Exam is sensitive to cognitive and pathological changes in preclinical autosomal dominant Alzheimer's disease. Alzheimer's Research & Therapy. 12: 104. PMID 32912283 DOI: 10.1186/s13195-020-00671-w  0.539
2020 Amariglio RE, Buckley RF, Rabin JS, Papp KV, Quiroz YT, Mormino EC, Sparks KP, Johnson KA, Rentz DM, Sperling RA. Examining Cognitive Decline Across Black and White Participants in the Harvard Aging Brain Study. Journal of Alzheimer's Disease : Jad. PMID 32417775 DOI: 10.3233/JAD-191291  0.434
2020 Jacobs HIL, Augustinack JC, Schultz AP, Hanseeuw BJ, Locascio J, Amariglio RE, Papp KV, Rentz DM, Sperling RA, Johnson KA. The presubiculum links incipient amyloid and tau pathology to memory function in older persons. Neurology. PMID 32273431 DOI: 10.1212/WNL.0000000000009362  0.694
2020 Alegret M, Muñoz N, Roberto N, Rentz DM, Valero S, Gil S, Marquié M, Hernández I, Riveros C, Sanabria A, Perez-Cordon A, Espinosa A, Ortega G, Mauleón A, Abdelnour C, ... ... Papp KV, et al. A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory®) for the early detection of Alzheimer's disease. Alzheimer's Research & Therapy. 12: 25. PMID 32178724 DOI: 10.1186/s13195-020-00594-6  0.503
2020 Putcha D, Dickerson BC, Brickhouse M, Johnson KA, Sperling RA, Papp KV. Word retrieval across the biomarker-confirmed Alzheimer's disease syndromic spectrum. Neuropsychologia. 107391. PMID 32057937 DOI: 10.1016/j.neuropsychologia.2020.107391  0.481
2020 Rentz DM, Papp KV. Commentary on Composite cognitive and functional measures for early stage Alzheimer's disease trials Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 12. DOI: 10.1002/dad2.12012  0.492
2019 Vila-Castelar C, Papp KV, Amariglio RE, Torres VL, Baena A, Gomez D, Rendon J, Samaroo A, Lopera F, Rentz DM, Quiroz YT. Validation of the Latin American Spanish version of the face-name associative memory exam in a Colombian Sample. The Clinical Neuropsychologist. 1-12. PMID 31851865 DOI: 10.1080/13854046.2019.1690050  0.392
2019 Vannini P, Uquillas FD, Jacobs HIL, Sepulcre J, Gatchel J, Amariglio RE, Hanseeuw B, Papp KV, Hedden T, Rentz DM, Pascual-Leone A, Johnson KA, Sperling RA. Decreased meta-memory is associated with early tauopathy in cognitively unimpaired older adults. Neuroimage. Clinical. 24: 102097. PMID 31795044 DOI: 10.1016/J.Nicl.2019.102097  0.673
2019 Papp KV, Buckley R, Mormino E, Maruff P, Villemagne VL, Masters CL, Johnson KA, Rentz DM, Sperling RA, Amariglio RE. Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31759879 DOI: 10.1016/J.Jalz.2019.09.074  0.581
2019 Buckley RF, Sikkes S, Villemagne VL, Mormino EC, Rabin JS, Burnham S, Papp KV, Doré V, Masters CL, Properzi MJ, Schultz AP, Johnson KA, Rentz DM, Sperling RA, Amariglio RE. Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 670-678. PMID 31673597 DOI: 10.1016/j.dadm.2019.08.004  0.518
2019 Hanseeuw BJ, Betensky RA, Jacobs HIL, Schultz AP, Sepulcre J, Becker JA, Cosio DMO, Farrell M, Quiroz YT, Mormino EC, Buckley RF, Papp KV, Amariglio RA, Dewachter I, Ivanoiu A, et al. Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study. Jama Neurology. PMID 31157827 DOI: 10.1001/Jamaneurol.2019.1424  0.708
2019 Yang HS, Chhatwal JP, Xu J, White CC, Hanseeuw B, Rabin JS, Papp KV, Buckley RF, Schultz AP, Properzi MJ, Gatchel JR, Amariglio RE, Donovan NJ, Mormino EC, Hedden T, et al. An UNC5C Allele Predicts Cognitive Decline and Hippocampal Atrophy in Clinically Normal Older Adults. Journal of Alzheimer's Disease : Jad. PMID 30883345 DOI: 10.3233/Jad-180788  0.487
2019 Buckley RF, Mormino EC, Rabin JS, Hohman TJ, Landau S, Hanseeuw BJ, Jacobs HIL, Papp KV, Amariglio RE, Properzi MJ, Schultz AP, Kirn D, Scott MR, Hedden T, Farrell M, et al. Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured By Positron Emission Tomography in Clinically Normal Older Adults. Jama Neurology. PMID 30715078 DOI: 10.1001/Jamaneurol.2018.4693  0.657
2019 Marshall GA, Gatchel JR, Donovan NJ, Muniz MC, Schultz AP, Becker JA, Chhatwal JP, Hanseeuw BJ, Papp KV, Amariglio RE, Rentz DM, Sperling RA, Johnson KA. Regional Tau Correlates of Instrumental Activities of Daily Living and Apathy in Mild Cognitive Impairment and Alzheimer's Disease Dementia. Journal of Alzheimer's Disease : Jad. 67: 757-768. PMID 30689584 DOI: 10.3233/Jad-170578  0.555
2019 Djonlagic I, Chhatwal J, Schulz A, Hampton O, Kirn D, Papp K, Rentz D, Johnson K, Sperling R, Redline S. 0300 Linking Sleep Disturbances with Amyloid and Tau Imaging. Preliminary Findings from the Harvard Aging Brain Study Sleep. 42: A122-A123. DOI: 10.1093/Sleep/Zsz067.299  0.31
2018 Sperling RA, Mormino EC, Schultz AP, Betensky RA, Papp KV, Amariglio RE, Hanseeuw BJ, Buckley R, Chhatwal J, Hedden T, Marshall GA, Quiroz YT, Donovan NJ, Jackson J, Gatchel JR, et al. The impact of Aβ and tau on prospective cognitive decline in older individuals. Annals of Neurology. PMID 30549303 DOI: 10.1002/Ana.25395  0.741
2018 Huijbers W, Schultz AP, Papp KV, LaPoint MR, Hanseeuw B, Chhatwal JP, Hedden T, Johnson KA, Sperling RA. Tau accumulation in clinically normal older adults is associated with hippocampal hyperactivity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30482786 DOI: 10.1523/Jneurosci.1397-18.2018  0.531
2018 Guzmán-Vélez E, Jaimes S, Aguirre-Acevedo DC, Norton DJ, Papp KV, Amariglio R, Rentz D, Baena A, Henao E, Tirado V, Muñoz C, Giraldo M, Sperling RA, Lopera F, Quiroz YT. A Three-Factor Structure of Cognitive Functioning Among Carriers and Non-Carriers of Autosomal-Dominant Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 30040714 DOI: 10.1093/Arclin/Acw043.34  0.564
2018 Buckley RF, Mormino EC, Amariglio RE, Properzi MJ, Rabin JS, Lim YY, Papp KV, Jacobs HIL, Burnham S, Hanseeuw BJ, Doré V, Dobson A, Masters CL, Waller M, Rowe CC, et al. Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29803541 DOI: 10.1016/J.Jalz.2018.04.010  0.715
2018 Rabin JS, Schultz AP, Hedden T, Viswanathan A, Marshall GA, Kilpatrick E, Klein H, Buckley RF, Yang HS, Properzi M, Rao V, Kirn DR, Papp KV, Rentz DM, Johnson KA, et al. Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study. Jama Neurology. PMID 29799986 DOI: 10.1001/Jamaneurol.2018.1123  0.556
2018 Hanseeuw BJ, Betensky RA, Mormino EC, Schultz AP, Sepulcre J, Becker JA, Jacobs HIL, Buckley RF, LaPoint MR, Vanini P, Donovan NJ, Chhatwal JP, Marshall GA, Papp KV, Amariglio RE, et al. PET staging of amyloidosis using striatum. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29792874 DOI: 10.1016/J.Jalz.2018.04.011  0.634
2018 Mormino EC, Papp KV. Amyloid Accumulation and Cognitive Decline in Clinically Normal Older Individuals: Implications for Aging and Early Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 29782318 DOI: 10.3233/JAD-179928  0.588
2018 Orlovsky I, Huijbers W, Hanseeuw BJ, Mormino EC, Hedden T, Buckley RF, LaPoint M, Rabin JS, Rentz DM, Johnson KA, Sperling RA, Papp KV. The relationship between recall of recently versus remotely encoded famous faces and amyloidosis in clinically normal older adults. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 121-129. PMID 29780861 DOI: 10.1016/J.Dadm.2017.11.003  0.469
2018 Jacobs HIL, Hedden T, Schultz AP, Sepulcre J, Perea RD, Amariglio RE, Papp KV, Rentz DM, Sperling RA, Johnson KA. Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals. Nature Neuroscience. PMID 29403032 DOI: 10.1038/s41593-018-0070-z  0.696
2017 Papp KV, Rentz DM, Orlovsky I, Sperling RA, Mormino EC. Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5. Alzheimer's & Dementia (New York, N. Y.). 3: 668-677. PMID 29264389 DOI: 10.1016/j.trci.2017.10.004  0.561
2017 Buckley RF, Sparks KP, Papp KV, Dekhtyar M, Martin C, Burnham S, Sperling RA, Rentz DM. Computerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 Batteries. The Journal of Prevention of Alzheimer's Disease. 4: 3-11. PMID 29188853 DOI: 10.14283/jpad.2017.1  0.452
2017 Gatchel JR, Donovan NJ, Locascio JJ, Schultz AP, Becker JA, Chhatwal J, Papp KV, Amariglio RE, Rentz DM, Blacker D, Sperling RA, Johnson KA, Marshall GA. Depressive Symptoms and Tau Accumulation in the Inferior Temporal Lobe and Entorhinal Cortex in Cognitively Normal Older Adults: A Pilot Study. Journal of Alzheimer's Disease : Jad. PMID 28697559 DOI: 10.3233/Jad-170001  0.473
2017 Buckley RF, Schultz AP, Hedden T, Papp KV, Hanseeuw BJ, Marshall G, Sepulcre J, Smith EE, Rentz DM, Johnson KA, Sperling RA, Chhatwal JP. Functional network integrity presages cognitive decline in preclinical Alzheimer disease. Neurology. PMID 28592457 DOI: 10.1212/Wnl.0000000000004059  0.513
2017 Dekhtyar M, Papp KV, Buckley R, Jacobs HIL, Schultz AP, Johnson KA, Sperling RA, Rentz DM. Neuroimaging Markers Associated with Maintenance of Optimal Memory Performance in Late-Life. Neuropsychologia. PMID 28472627 DOI: 10.1016/j.neuropsychologia.2017.04.037  0.581
2017 Papp KV, Rentz DM, Mormino EC, Schultz AP, Amariglio RE, Quiroz Y, Johnson KA, Sperling RA. Cued memory decline in biomarker-defined preclinical Alzheimer disease. Neurology. PMID 28283594 DOI: 10.1212/Wnl.0000000000003812  0.488
2017 Hanseeuw BJ, Betensky RA, Schultz AP, Papp KV, Mormino EC, Sepulcre J, Bark JS, Cosio DM, LaPoint M, Chhatwal JP, Rentz DM, Sperling RA, Johnson K. FDG metabolism associated with tau-amyloid interaction predicts memory decline. Annals of Neurology. PMID 28253546 DOI: 10.1002/Ana.24910  0.482
2017 Mormino EC, Papp KV, Rentz DM, Donohue MC, Amariglio R, Quiroz YT, Chhatwal J, Marshall GA, Donovan N, Jackson J, Gatchel JR, Hanseeuw BJ, Schultz AP, Aisen PS, Johnson KA, et al. Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated β-amyloid. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28253478 DOI: 10.1016/J.Jalz.2017.01.018  0.562
2016 Rentz DM, Mormino EC, Papp KV, Betensky RA, Sperling RA, Johnson KA. Cognitive resilience in clinical and preclinical Alzheimer's disease: the Association of Amyloid and Tau Burden on cognitive performance. Brain Imaging and Behavior. PMID 27738998 DOI: 10.1007/s11682-016-9640-4  0.546
2016 Huijbers W, Papp KV, LaPoint M, Wigman SE, Dagley A, Hedden T, Rentz DM, Schultz AP, Sperling RA. Age-Related Increases in Tip-of-the-tongue are Distinct from Decreases in Remembering Names: A Functional MRI Study. Cerebral Cortex (New York, N.Y. : 1991). PMID 27578492 DOI: 10.1093/Cercor/Bhw234  0.362
2016 Mormino EC, Papp KV, Rentz DM, Schultz AP, LaPoint M, Amariglio R, Hanseeuw B, Marshall GA, Hedden T, Johnson KA, Sperling RA. Heterogeneity in Suspected Non-Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals. Jama Neurology. PMID 27548655 DOI: 10.1001/jamaneurol.2016.2237  0.474
2016 Mormino EC, Papp KV. Cognitive Decline in Preclinical Stage 2 Alzheimer Disease and Implications for Prevention Trials. Jama Neurology. PMID 27064971 DOI: 10.1001/jamaneurol.2016.0281  0.525
2016 Gatchel JR, Donovan NJ, Blacker D, Schultz AP, Becker A, Chhatwal J, Papp KV, Amariglio RE, Rentz DM, Sperling RA, Johnson KA, Marshall GA. Investigating the Association between Depressive Symptoms and Cortical Tau Across the Alzheimer's Disease Spectrum The American Journal of Geriatric Psychiatry. 24: S96-S97. DOI: 10.1016/J.Jagp.2016.01.096  0.367
2015 Papp KV, Mormino EC, Amariglio RE, Munro C, Dagley A, Schultz AP, Johnson KA, Sperling RA, Rentz DM. Biomarker Validation of a Decline in Semantic Processing in Preclinical Alzheimer's Disease. Neuropsychology. PMID 26595826 DOI: 10.1037/neu0000246  0.514
2015 Johnson KA, Schultz A, Betensky RA, Becker JA, Sepulcre J, Rentz D, Mormino E, Chhatwal J, Amariglio R, Papp K, Marshall G, Albers M, Mauro S, Pepin L, Alverio J, et al. Tau PET imaging in aging and early Alzheimer's disease. Annals of Neurology. PMID 26505746 DOI: 10.1002/Ana.24546  0.349
2015 Papp KV, Amariglio RE, Mormino EC, Hedden T, Dekhytar M, Johnson KA, Sperling RA, Rentz DM. Free and cued memory in relation to biomarker-defined abnormalities in clinically normal older adults and those at risk for Alzheimer's disease. Neuropsychologia. 73: 169-75. PMID 26002757 DOI: 10.1016/j.neuropsychologia.2015.04.034  0.538
2015 Papp KV, Mormino EC, Amariglio R, Schultz AP, Johnson KA, Sperling RA, Rentz DM. O2-02-05: Differential declines in letter versus category fluency over 4 years in biomarker-defined preclinical Alzheimer's disease Alzheimer's & Dementia. 11: P176-P177. DOI: 10.1016/j.jalz.2015.07.140  0.396
2015 Rentz DM, Mormino EC, Amariglio R, Papp KV, Sperling RA, Johnson KA. O2-02-03: The relationship of cognition, cognitive reserve, and in vivo tau and amyloid burden Alzheimer's & Dementia. 11: P175-P175. DOI: 10.1016/j.jalz.2015.07.138  0.413
2015 Chute MP, Hsu DC, Wigman SE, Munro CE, Jaimes SY, Dagley AS, Mormino EC, Hedden T, Schultz AP, Papp KV, Amariglio R, Sperling RA, Rentz DM. Moderate caffeine consumption is associated with better memory scores in clinically normal older adults Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.1589  0.348
2015 Sperling RA, Mormino EC, Rentz DM, Schultz AP, Sepulcre J, Hedden T, Chhatwal JP, Marshall GA, Amariglio R, Papp KV, Johnson KA. IC-P-085: Regional Tau PET measures associated with memory performance in clinically normal older individuals Alzheimer's & Dementia. 11: P60-P61. DOI: 10.1016/J.Jalz.2015.06.106  0.388
2015 Rentz DM, Mormino EC, Amariglio R, Papp KV, Schultz AP, Sperling RA, Johnson KA. IC-P-068: The relationship of cognition, cognitive reserve, and in vivo tau and amyloid burden Alzheimer's & Dementia. 11: P51-P51. DOI: 10.1016/j.jalz.2015.06.089  0.5
2014 Papp KV, Amariglio RE, Dekhtyar M, Roy K, Wigman S, Bamfo R, Sherman J, Sperling RA, Rentz DM. Development of a psychometrically equivalent short form of the Face-Name Associative Memory Exam for use along the early Alzheimer's disease trajectory. The Clinical Neuropsychologist. 28: 771-85. PMID 24815535 DOI: 10.1080/13854046.2014.911351  0.505
2014 Wayne PM, Walsh JN, Taylor-Piliae RE, Wells RE, Papp KV, Donovan NJ, Yeh GY. Effect of tai chi on cognitive performance in older adults: systematic review and meta-analysis. Journal of the American Geriatrics Society. 62: 25-39. PMID 24383523 DOI: 10.1111/Jgs.12611  0.472
2014 Papp KV, Kaplan RF, Springate B, Moscufo N, Wakefield DB, Guttmann CR, Wolfson L. Processing speed in normal aging: effects of white matter hyperintensities and hippocampal volume loss. Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition. 21: 197-213. PMID 23895570 DOI: 10.1080/13825585.2013.795513  0.59
2013 Papp KV, Snyder PJ, Mills JA, Duff K, Westervelt HJ, Long JD, Lourens S, Paulsen JS. Measuring executive dysfunction longitudinally and in relation to genetic burden, brain volumetrics, and depression in prodromal Huntington disease. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 28: 156-68. PMID 23246934 DOI: 10.1093/Arclin/Acs105  0.54
2012 Papp KV, Snyder PJ. Editorial to accompany--training the brain: fact and fad in cognitive and behavioral remediation. Brain and Cognition. 79: 158. PMID 22510611 DOI: 10.1016/j.bandc.2012.03.005  0.522
2011 Papp KV, Kaplan RF, Snyder PJ. Biological markers of cognition in prodromal Huntington's disease: a review. Brain and Cognition. 77: 280-91. PMID 21889251 DOI: 10.1016/J.Bandc.2011.07.009  0.714
2011 Papp KV, Snyder PJ, Maruff P, Bartkowiak J, Pietrzak RH. Detecting subtle changes in visuospatial executive function and learning in the amnestic variant of mild cognitive impairment. Plos One. 6: e21688. PMID 21779333 DOI: 10.1371/journal.pone.0021688  0.614
2009 Snyder PJ, Papp KV, Bartkowiak J, Jackson CE, Doody RS. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Recruitment of participants for Alzheimer's disease clinical trials: the role of trust in caregivers, clinical researchers, regulatory authorities, and industry sponsors. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 122-4. PMID 19328439 DOI: 10.1016/j.jalz.2009.01.016  0.618
2009 Papp KV, Walsh SJ, Snyder PJ. Immediate and delayed effects of cognitive interventions in healthy elderly: a review of current literature and future directions. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 50-60. PMID 19118809 DOI: 10.1016/J.Jalz.2008.10.008  0.623
2009 Papp KV, Snyder PJ, Maruff P, Pietrzak RH, Bartkowiak J, Harrison J. P3-054: Focal spatial memory dysfunction in mild cognitive impairment: Amnestic variant Alzheimer's & Dementia. 5: P357-P357. DOI: 10.1016/j.jalz.2009.04.1130  0.661
2009 Jackson CE, Snyder PJ, Papp KV, Bartkowiak J. P3-229: Dementia literacy: Public understanding of known risk factors Alzheimer's & Dementia. 5: P410-P411. DOI: 10.1016/j.jalz.2009.04.1002  0.589
2006 Papp KV, Rentz DM, Maruff P, Sun C, Raman R, Donohue MC, Schembri A, Stark CE, Yassa MA, Holdridge KC, Wessels AM, Yaari R, Aisen PS, Sperling RA. P4-341: THE COMPUTERIZED COGNITIVE COMPOSITE (C3) AND AMYLOID STATUS AMONG NORMAL OLDER ADULTS Alzheimer's & Dementia. 14: P1597-P1598. DOI: 10.1016/J.Jalz.2018.07.164  0.437
2006 Vannini P, Uquillas Fd, Jacobs H, Sepulcre J, Gatchel JR, Amariglio R, Hanseeuw BJ, Hedden T, Rentz DM, Pascual-Leone A, Papp KV, Johnson KA, Sperling RA. O3-12-01: DECREASED META-MEMORY FOR EPISODIC BUT NOT SEMANTIC INFORMATION IS ASSOCIATED WITH EARLY TAUOPATHY IN CLINICALLY NORMAL OLDER ADULTS Alzheimer's & Dementia. 14: P1050-P1050. DOI: 10.1016/j.jalz.2018.06.2837  0.341
2006 Buckley RF, Mormino BC, Hanseeuw BJ, Jacobs HI, Papp KV, Amariglio R, Properzi MJ, Schultz AP, Scott MR, Kirn D, Chhatwal JP, Rabin JS, Rentz DM, Villemagne VL, Johnson KA, et al. O3-04-03: AMYLOID IS ASSOCIATED WITH GREATER TAU BURDEN IN CLINICALLY NORMAL FEMALES RELATIVE TO MALES: FINDINGS FROM TWO INDEPENDENT COHORTS Alzheimer's & Dementia. 14: P1019-P1020. DOI: 10.1016/J.Jalz.2018.06.2790  0.345
2006 Papp KV, Rentz DM, Burnham SC, Orlovsky I, Souillard-Mandar W, Penney DL, Davis R, Sperling RA, Johnson KA. O1-08-03: DIGITIZED CLOCK DRAWING (DCTCLOCKTM ) PERFORMANCE AND ITS RELATIONSHIP TO AMYLOID AND TAU PET IMAGING MARKERS IN UNIMPAIRED OLDER ADULTS Alzheimer's & Dementia. 14: P236-P237. DOI: 10.1016/J.Jalz.2018.06.2374  0.347
2006 Hedden T, Buckley RF, Downey NR, Hohman TJ, Johnson KA, Papp KV, Rentz DM, Sperling RA. IC-P-159: BRAIN RESILIENCE PROTECTS AGAINST COGNITIVE DECLINE ASSOCIATED WITH ELEVATED AMYLOID BURDEN Alzheimer's & Dementia. 14: P134-P135. DOI: 10.1016/J.Jalz.2018.06.2226  0.443
2006 Papp KV, Mormino BC, Grober E, Quiroz YT, Schultz AP, Sperling RA, Johnson KA, Rentz DM. IC-P-147: QUANTIFYING STAGES OF SUBTLE MEMORY IMPAIRMENT IN PRECLINICAL ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P125-P126. DOI: 10.1016/j.jalz.2018.06.2213  0.418
Show low-probability matches.